Abeona Therapeutics Inc vs Omnicom Group Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Omnicom Group Inc. trades at $85.74 (market cap $23.58B). The key difference: Omnicom Group Inc. is far larger — about 56× Abeona Therapeutics Inc's market cap, and Omnicom Group Inc. pays a 3.72% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | OMC | |
|---|---|---|
Market Cap | $421.19M | $23.58B |
Sector | Health | Media |
52-Week High | $7.45 | $86.22 |
52-Week Low | $4.17 | $67.27 |
Enterprise Value | $276.10M | $31.66B |
Dividend Yield | — | 3.72% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →